Litcius/Paper detail

m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer

Xinming Yin, Shijie Zhao, Mengxue Zhang, Jie Xing, Jiamin Zhou, Wujiang Gao, Lu Chen, Yajiao Zhang, Li Lin, Minjun Lu, Wenxin Li, Junyu Shang, Xiaolan Zhu

2023Gynecologic Oncology17 citationsDOIOpen Access PDF

Topics & Concepts

Downregulation and upregulationCisplatinIn vivoOvarian cancerCancer researchOncogeneMessenger RNARNAIn vitroMedicineCancerBiologyChemotherapyInternal medicineCell cycleGeneBiochemistryBiotechnologyRNA modifications and cancerRNA and protein synthesis mechanismsMetalloenzymes and iron-sulfur proteins
m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer | Litcius